About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Janet Rowley Prize: Special Lecture
Scientific Session 1: Top Scoring Abstracts 2018
Scientific Session 2: Stem Cells and the Microenvironment
Symposium on Some Emerging and Remaining Challenges in MPN’s
Scientific Session 3: The Microenvironment and Mechanisms of Transformation
Special Lecture
Scientific Session 4: Mechanisms of Resistance
Scientific Session 5: Mechanisms of Resistance and New Targets
Symposium on Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Brief Oral Communications (Biology)
Brief Oral Communications (Clinical)
Scientific Session 6: Therapeutic Interventions
Scientific Session 7: Treatment-free Remission
Scientific Session 8: Monitoring, Biomarkers and Other Approaches
iCMLf Prize: Special Lecture
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
What Prevents the Disease from Relapsing after TKI Discontinuation
By
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
FEATURING
Satu Mustjoki
By
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
FEATURING
Satu Mustjoki
8 views
December 3, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Scientific Session 7: Treatment-free Remission
12:56
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Molecular Milestones Using the BCR-ABL1 qPCR Level and Doubling Time…
Feat.
D. Kim
18:28
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
What Prevents the Disease from Relapsing after TKI Discontinuation
Feat.
S. Mustjoki
11:10
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Treatment-free Remission in Patients with Chronic Phase Chronic Myel…
Feat.
S. Saussele